NCT00429273
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
See it on ClinicalTrials.gov β207 people
31.4%
68.6%
65 womenmiddle line = equal numbers142 men
- Phase
- PHASE4
- Paid for by
- University of California, Los Angeles
- Finished
- 2011-07
- Health conditions
- Attention Deficit Disorder With Hyperactivity
- Who could join
- Anyone
- Ages
- 7 Years β 14 Years
- Average age
- mean 10.0 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 57% Β· Hispanic / Latina 17.5% Β· Black / African American 14.3% Β· Native Hawaiian / Pacific Islander 6.4% Β· Other 4.8%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
βMaximum age: 14 Years.β
- No pregnant women
Women who were pregnant could not join.
βPregnant, breastfeeding, or beyond menarche and has a positive urine pregnancy testβ
- No breastfeeding moms
Women who were breastfeeding could not join.
βPregnant, breastfeeding, or beyond menarche and has a positive urine pregnancy testβ
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
βSystolic or diastolic blood pressure at screening greater than the 95th percentile or less than the 5th percentile for age and body mass index (BMI)β
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
βHistory of autism, pervasive developmental disorder, chronic tic disorder, psychosis, or bipolar disorderβ
Study titles and rules are shown in their original English.